A team of researchers from the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET, Milan), led by Nadia Coltella and ...

Cell Death & Differentiation - Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy Skip to main content Thank you for visiting ...

In their paper they stated “Our study identifies a promising multi-targetable PTP4A–ROBO1 signaling axis that drives tumorigenicity in recurrent GBM, with potential in other malignant brain ...

Inhaled CBD shrinks the size of the highly aggressive, lethal brain tumor glioblastoma in an animal model by reducing the essential support of its microenvironment, researchers report. Skip to content ...

Researchers used lab-grown organoids created from tumors of individuals with glioblastoma (GBM) to accurately model a patient's response to CAR T cell therapy in real time. The organoid's response ...

Glioblastoma is an aggressive disease partially because it is unpredictable: when the heterogeneous cancer cells are injected separately into model animals, the cancer will remain dormant in some ...

AUGUSTA, Ga. (Dec. 23, 2021) Inhaled CBD shrinks the size of the highly aggressive, lethal brain tumor glioblastoma in an animal model by reducing the essential support of its microenvironment ...

The output of this model is the spatial tumor cell density over time, ... Response classification based on a minimal model of glioblastoma growth is prognostic for clinical outcomes and distinguishes ...

Unique, new GBM therapy gets Fast Track Designation from FDA Diakonos Oncology Awarded FDA Fast Track Designation for Innovative Dendritic Cell Vaccine for Glioblastoma October 17, 2023 05:30 AM ...